Skip to main content
. 2013 Oct 12;6:148. doi: 10.1186/1754-6834-6-148

Figure 1.

Figure 1

The structures of xylo-oligosaccharides used in this study. A3X, α-L-arabinofuranosyl-(1→3)-β-D-xylopyranosyl-(1→4)-D-xylose; Ad2+3XX, α-L-arabinofuranosyl-(1→2)-[α-L-arabinofuranosyl-(1→3)]-β-D-xylopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-D-xylose; U4m2XX, 4-O-methyl-α-D-glucopyranosyl uronic acid-(1→2)-β-D-xylopyranosyl-(1→4)-β-D-xylopyranosyl-(1→4)-D-xylose.